Filing Details

Accession Number:
0001179110-20-004829
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-10 17:29:56
Reporting Period:
2020-04-08
Accepted Time:
2020-04-10 17:29:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1280600 Acceleron Pharma Inc XLRN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1214938 F Kevin Mclaughlin 128 Sidney Street
Cambridge MA 02139
Svp, Cfo And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-08 4,000 $24.11 15,216 No 4 M Direct
Common Stock Acquisiton 2020-04-08 12,774 $41.20 27,990 No 4 M Direct
Common Stock Acquisiton 2020-04-08 10,000 $27.97 37,990 No 4 M Direct
Common Stock Acquisiton 2020-04-08 10,000 $30.17 47,990 No 4 M Direct
Common Stock Disposition 2020-04-08 2,900 $82.83 45,090 No 4 S Direct
Common Stock Disposition 2020-04-08 5,037 $83.68 40,053 No 4 S Direct
Common Stock Disposition 2020-04-08 3,803 $84.89 36,250 No 4 S Direct
Common Stock Disposition 2020-04-08 15,410 $85.80 20,840 No 4 S Direct
Common Stock Disposition 2020-04-08 5,921 $86.79 14,919 No 4 S Direct
Common Stock Disposition 2020-04-08 3,703 $87.50 11,216 No 4 S Direct
Common Stock Acquisiton 2020-04-09 17,226 $41.20 28,442 No 4 M Direct
Common Stock Disposition 2020-04-09 17,226 $88.19 11,216 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock Disposition 2020-04-08 4,000 $0.00 4,000 $24.11
Common Stock Option to Purchase Common Stock Disposition 2020-04-08 12,774 $0.00 12,774 $41.20
Common Stock Option to Purchase Common Stock Disposition 2020-04-08 10,000 $0.00 10,000 $27.97
Common Stock Option to Purchase Common Stock Disposition 2020-04-08 10,000 $0.00 10,000 $30.17
Common Stock Option to Purchase Common Stock Disposition 2020-04-09 17,226 $0.00 17,226 $41.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-12-05 No 4 M Direct
28,226 2025-01-08 No 4 M Direct
8,300 2026-03-03 No 4 M Direct
31,300 2017-03-02 No 4 M Direct
11,000 2025-01-08 No 4 M Direct
Footnotes
  1. The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.19 to $83.13 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.20 to $84.13 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.23 to $85.22 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.26 to $86.21 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.31 to $87.30 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (6) to this Form 4.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.31 to $88.03 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (7) to this Form 4.
  8. The shares of common stock underlying this stock option award vested in equal quarterly installments over the four years after the grant.
  9. The shares of common stock underlying this stock option award vested in equal quarterly installments over the four years after January 1, 2016.
  10. The shares of common stock underlying this stock option award vest in equal quarterly installments over the four years after January 1, 2017.